Cargando…
Skeletal Muscle Deconditioning in Breast Cancer Patients Undergoing Chemotherapy: Current Knowledge and Insights From Other Cancers
Breast cancer represents the most commonly diagnosed cancer while neoadjuvant and adjuvant chemotherapies are extensively used in order to reduce tumor development and improve disease-free survival. However, chemotherapy also leads to severe off-target side-effects resulting, together with the tumor...
Autores principales: | Mallard, Joris, Hucteau, Elyse, Hureau, Thomas J., Pagano, Allan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476809/ https://www.ncbi.nlm.nih.gov/pubmed/34595171 http://dx.doi.org/10.3389/fcell.2021.719643 |
Ejemplares similares
-
Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer
por: Mallard, Joris, et al.
Publicado: (2022) -
Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy
por: Mallard, Joris, et al.
Publicado: (2022) -
Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy
por: Hucteau, Elyse, et al.
Publicado: (2023) -
Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients
por: Mallard, Joris, et al.
Publicado: (2022) -
Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol
por: Mallard, Joris, et al.
Publicado: (2020)